Phase 3 Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been recently diagnosed with multiple myeloma (a type of blood cancer) according to standard diagnostic guidelines, and a bone marrow transplant is not a suitable option for you.
- Your multiple myeloma can be measured and tracked through tests (meaning there are clear signs of the disease that can be monitored).
- Your heart, liver, kidneys, and blood counts are working well enough to meet the study's requirements.
- You are willing to use contraception during the study and for 5 months after the last dose, and you agree not to donate eggs or sperm during this time.
Who may not be able to join:
- You have another type of blood cancer in addition to multiple myeloma.
- There is evidence or suspicion that the cancer has spread to your brain or the fluid around your brain or spinal cord.
- You have an infection that is not currently under control.
- You have a serious ongoing health condition affecting your heart, lungs, hormones, immune system, liver, or digestive system, or you have another type of cancer — and your doctor considers this to be a significant concern (confirm with trial site).
- You have had major surgery or a serious injury within the 4 weeks before starting the trial, or you are expected to need planned surgery during the trial.
- You have received a live or weakened vaccine within 30 days before your first dose, or you are currently breastfeeding.
- You have a mental health condition, difficulty following medical instructions, or any other reason the trial doctors feel makes participation unsuitable for you (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression free survival (PFS); Minimal residual disease (MRD) negativity rate for participants with CR
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.